75A50123C00053
Definitive Contract
Overview
Government Description
Atelerix - the overall objective of this contract is to plan and execute a phase 1A clinical trial (hereafter referred to as the ?phase 1A trial?) of the novel small molecule ATLX-0199 in 30 normal healthy subjects. The goal of the clinical trial is
Awardee
Awarding / Funding Agency
Place of Performance
Charlottesville, VA 22902 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Competed Under Simplified Acquisition Procedures
Related Opportunity
EZBAA22100SOL00003
Analysis Notes
Termination This definitive contract was terminated for convenience (partial or complete) in July 2024.
Amendment Since initial award the Potential End Date has been shortened from 02/27/26 to 07/23/24 and the Potential Award value has decreased 91% from $749,000 to $68,115.
Amendment Since initial award the Potential End Date has been shortened from 02/27/26 to 07/23/24 and the Potential Award value has decreased 91% from $749,000 to $68,115.
Atelerix Life Sciences was awarded
Definitive Contract 75A50123C00053 (75A501-23-C-00053)
worth up to $68,115
by the HHS Office of the Assistant Secretary for Preparedness and Response
in September 2023.
The contract
has a duration of 10 months and
was awarded
full & open
with
NAICS 541715 and
PSC AN13
via simplified acquisition acquisition procedures with 100 bids received.
Status
(Complete)
Last Modified 12/4/24
Period of Performance
9/14/23
Start Date
7/23/24
Current End Date
7/23/24
Potential End Date
Obligations
$68.1K
Total Obligated
$68.1K
Current Award
$68.1K
Potential Award
Award Hierarchy
Definitive Contract
75A50123C00053
Subcontracts
Activity Timeline
Transaction History
Modifications to 75A50123C00053
People
Suggested agency contacts for 75A50123C00053
Competition
Number of Bidders
100
Solicitation Procedures
Simplified Acquisition
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
TD8NL4UWNVW8
Awardee CAGE
8ZNE9
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
750501
Created By
hhschristophermuntz
Last Modified By
hhschristophermuntz
Approved By
hhschristophermuntz
Legislative
Legislative Mandates
None Applicable
Performance District
VA-05
Senators
Mark Warner
Timothy Kaine
Timothy Kaine
Representative
Robert Good
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services (075-0140) | Health care services | Advisory and assistance services (25.1) | $749,000 | 100% |
Modified: 12/4/24